Feb 11 (Reuters) - SenzaGen AB SENZA.ST :
* SENZAGEN’S YEAR-END REPORT 2021: STRONG PERFORMANCE WITH
MORE
THAN 150% GROWTH IN H2 AND NEARLY DOUBLED SALES FOR FULL YEAR
* H2 OPERATING LOSS SEK 17.5 MILLION VERSUS SEK LOSS 14.2
MILLION
YEAR AGO
* H2 NET SALES SEK 10.4 MILLION VERSUS SEK 4.1 MILLION YEAR
AGO
* BOARD PROPOSES THAT NO DIVIDEND BE PAID TO COMPANY'S
SHAREHOLDERS
* SALES GROWTH WILL REMAIN OUR HIGHEST PRIORITY IN 2022
WHILE WE
CONTINUE WORKING ON OUR ACQUISITION AGENDA, INTEGRATION OF
VITROSCREEN AND COMPLETING OECD TEST GUIDELINE PROCESS FOR
GARD®SKIN
Source text for Eikon: ID:nMFN32lR4X
Further company coverage: SENZA.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;;))